Baltmedis - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 224,036 | 50,231 | 52,668 | 20,370 | 18,179 | 32,134 | 110,355 | 229,098 |
| Profit before tax | -2,630 | -5,897 | -228 | 13,271 | 14,415 | 386 | 8,704 | 8,318 |
| Net profit | -2,630 | -5,897 | -228 | 12,955 | 13,716 | 367 | 8,269 | 7,819 |
| Equity | 12,365 | 6,468 | 6,239 | 19,194 | 32,910 | 33,277 | 41,546 | 49,365 |
| Liabilities | 6,358 | 6,503 | 3,981 | 1,850 | 727 | 94 | 11,053 | 1,092 |
| Non-current assets | 4,828 | 3,350 | 0 | 0 | 0 | 3,512 | 24,537 | 22,000 |
| Current assets | 13,895 | 9,621 | 10,220 | 21,044 | 33,637 | 29,859 | 27,995 | 28,384 |
| Total assets | 18,723 | 12,971 | 10,220 | 21,044 | 33,637 | 33,371 | 52,532 | 50,384 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 500 | - | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -62.4% | -77.6% | +4.9% | -61.3% | -10.8% | +76.8% | +243.4% | +107.6% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -14.0% | -45.5% | -2.2% | 61.6% | 40.8% | 1.1% | 15.7% | 15.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -21.3% | -91.2% | -3.7% | 67.5% | 41.7% | 1.1% | 19.9% | 15.8% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -1.2% | -11.7% | -0.4% | 63.6% | 75.4% | 1.1% | 7.5% | 3.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -1.2% | -11.7% | -0.4% | 65.1% | 79.3% | 1.2% | 7.9% | 3.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.5 | 1.0 | 0.6 | 0.1 | 0.0 | 0.0 | 0.3 | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 107,539 | 35,456 | 52,668 | 20,370 | 18,179 | 19,280 | 82,768 | 229,098 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Baltmedis - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-07-19 | 2026-07-21 | 0.66 |
| 2026-07-16 | 2026-07-17 | 0.66 |
| 2025-07-16 | 2025-07-20 | 3.70 |
| 2025-02-10 | 2025-02-10 | 5.55 |
| 2025-01-16 | 2025-01-29 | 5.55 |
| 2024-10-16 | 2024-10-20 | 3.68 |
| 2024-07-16 | 2024-07-17 | 5.82 |
| 2024-06-18 | 2024-06-30 | 0.38 |
| 2023-12-18 | 2023-12-20 | 4.66 |
| 2023-01-17 | 2023-01-17 | 0.04 |
| 2022-02-17 | 2022-02-20 | 6.08 |
Baltmedis - VMI tax arrears
| From | To | Overdue, € |
|---|---|---|
| 2025-06-19 | 2025-06-19 | 387.8 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Baltmedis, UAB (code 304230400) is a Private Limited Liability Company engaged in the wholesale of wood, construction materials and sanitary equipment. In 2025, the company generated EUR 229.1K in revenue, up 107.6% year on year and 613.0% over two years, reflecting a strong expansion in turnover. Net profit in 2025 was EUR 7.8K, with a profit margin of 3.4%. This followed a lower but still profitable 2024, when revenue reached EUR 110.4K and net profit EUR 8.3K, after 2023 revenue of EUR 32.1K and net profit of EUR 367. The revenue trend shows rapid growth, while profitability remained positive throughout the period, although the margin narrowed in 2025 compared with 2024. At the end of 2025, total assets stood at EUR 50.4K, equity at EUR 49.4K, and liabilities at EUR 1.1K. The equity ratio was 98.0%, debt-to-equity 0.02, ROE 15.8%, ROA 15.5%, and asset turnover 4.55x. Revenue per employee was EUR 229.1K and profit per employee EUR 7.8K.